Please wait...
About This Project
We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.
Browse Other Projects on Experiment
Related Projects
Developing a low-cost, rapid diagnostic for urogenital Schistosomiasis infection
We are developing a frugal diagnostic for urogenital schistosomiasis, a neglected tropical disease that...
Part 2: Can low carbohydrate ketogenic diets inhibit cancers?
We've identified that ketone bodies, i.e. fuels in the bloodstream that result from a very low carbohydrate...
How does involvement in kink, fetish or BDSM impact a person's health?
Kink-involved people engage in atypical erotic activities such as bondage, rough sex, and fetish activities...